Claypoole Robert E 4
4 · Bioventus Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Claypoole Robert E
DirectorPresident and CEO
Transactions
- Sale
Class A Common Stock
2025-01-13$9.10/sh−28,786$261,953→ 64,964 total
Footnotes (2)
- [F1]Reflects shares sold to cover taxes upon the vesting of restricted stock units on January 10, 2025 pursuant to a standing 10b5-1 instruction adopted on January 11, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.935 to $9.22, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.